fMRI Neurofeedback With Matter Neuroscience App
Not Applicable
Not yet recruiting
- Conditions
- Depression MildDepressionDepression Moderate
- Registration Number
- NCT06735885
- Lead Sponsor
- Stanford University
- Brief Summary
Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
- Male or Female, between the ages of 18 and 80 at the time of screening.
- Able to read, understand, and provide written, dated informed consent prior to screening. Proficiency in English sufficient to complete questionnaires / follow instructions during fMRI. Stated willingness to comply with all study procedures, including availability for the duration of the study, and to communicate with study personnel about adverse events and other clinically important information.
- Must possess an iPhone with iOS 17 or higher.
- Single-SSRI-resistant depressive disorder patients with a MADRS scale between 20-34
Read More
Exclusion Criteria
- Contraindication to MRI (ferromagnetic metal in their body)
- Claustrophobia
- Severe Major Depressive Disorder (MDD)
- MADRS scale of >34
- Treatment-resistant depression (TRD) from 3 or more treatments.
- Any other condition deemed by the PD to interfere with the study or increase risk to the participant
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Determine the safety and efficacy of neurofeedback for treating depression through MADRS scale changes 12 months Determine the safety and efficacy of neurofeedback for treating depression through MADRS scale changes
- Secondary Outcome Measures
Name Time Method